p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast

被引:56
作者
Done, SJ
Eskandarian, S
Bull, S
Redston, M
Andrulis, IL
机构
[1] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[2] Mt Sinai Hosp, Dept Lab Med & Pathol, Toronto, ON M5G 1X5, Canada
[3] Mt Sinai Hosp, Dept Publ Hlth Sci, Toronto, ON M5G 1X5, Canada
[4] Mt Sinai Hosp, Dept Mol & Med Genet, Toronto, ON M5G 1X5, Canada
[5] Mt Sinai Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
关键词
D O I
10.1093/jnci/93.9.700
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To understand the role of sporadic mutations in the turner suppressor gene p53 (also known as TP53) in the pathogenesis of breast dancer, it is important to identify at which histologic stage such mutations first occur. We previously showed that a p53 mutation present in invasive breast cancer was found in all surrounding areas of ductal carcinoma in situ (DCIS) but not in areas of hyperplasia or normal breast epithelium. In the present investigation, we studied patients with DCIS, but without invasive breast cancer, to determine the spectrum of DCIS types that can harbor a p53 mutation. Methods: Formalin-fixed, paraffin-embedded tissues from 94 patients with DCIS were evaluated histologically for the predominant cellular architectural pattern, degree of necrosis, and nuclear grade, Each specimen was also assigned an overall histologic grade (with the use of the Van Nuys Prognostic Index pathologic classification). Tissue specimens were stained Immunohistochemically with an anti-p53 antibody, Positively stained tissue areas were analyzed for the presence of p53 mutations by single-strand conformation polymorphism and direct sequencing. All statistical tests were two-sided, Results: DCIS from 10 of 94 patients were found to contain p53 missense mutations. All 10 were of a solid or a comedo histologic pattern and contained cells of nuclear grade 2 or 3 (i.e., more abnormal nuclei), The frequency of p53 missense mutations was statistically significantly; different among the three overall histologic grade categories (zero [0%] of 49 with low-grade DCIS, one [4.35%] of 23 with intermediate-grade DCIS, and nine [40.9%] of 22 with high-grade DCIS; df = 2 and P<.0001). Conclusion: The DCIS types in patients in this series are representative of clinically detected DCIS. Our finding that p53 mutations tan occur before the development of invasive breast cancer, particularly in DCIS of high histologic grade, has potentially important implications fur prevention and treatment.
引用
收藏
页码:700 / 704
页数:5
相关论文
共 14 条
  • [1] TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast
    Chitemerere, M
    Andersen, TI
    Holm, R
    Karlsen, F
    Borresen, AL
    Nesland, JM
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1996, 41 (02) : 103 - 109
  • [2] DAVIDOFF AM, 1991, CANCER RES, V51, P2605
  • [3] p53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers
    Done, SJ
    Arneson, NCR
    Özçelik, H
    Redston, M
    Andrulis, IL
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 65 (02) : 111 - 118
  • [4] Done SJ, 1998, CANCER RES, V58, P785
  • [5] THE P53 TUMOR-SUPPRESSOR GENE IN BREAST-CANCER
    ELLEDGE, RM
    ALLRED, DC
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (01) : 39 - 47
  • [6] Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer
    Lisboa, BW
    Vogtländer, S
    Gilster, T
    Riethdorf, L
    Milde-Langosch, K
    Löning, T
    [J]. VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1997, 431 (06): : 375 - 381
  • [7] p53 mutations and expression in breast carcinoma in situ
    Lukas, J
    Niu, N
    Press, MF
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (01) : 183 - 191
  • [8] P53 MUTATIONS IN BENIGN BREAST-TISSUE
    MILLIKAN, R
    HULKA, B
    THOR, A
    ZHANG, YC
    EDGERTON, S
    ZHANG, XX
    PEI, H
    HE, M
    WOLD, L
    MELTON, LJ
    BALLARD, D
    CONWAY, K
    LIU, ET
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2293 - 2300
  • [9] Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ
    Munn, KE
    Walker, RA
    Menasce, L
    Varley, JM
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (10) : 1578 - 1585
  • [10] OMALLEY FP, 1994, LAB INVEST, V71, P67